(Q38339567)

2 September 2017

title

Antisense Tcf inhibits the neoplastic growth of liver cancer cells (English)

1 reference

2 September 2017

1 reference

Ying Jiang

1

1 reference

2 September 2017

Xin-Da Zhou

2

1 reference

2 September 2017

Yin-Kun Liu

3

1 reference

2 September 2017

Xiao-Wu Huang

4

1 reference

2 September 2017

Yan Zhao

5

1 reference

2 September 2017

Qiang Xue

6

1 reference

2 September 2017

Rui-Xa Sun

7

1 reference

2 September 2017

Jie Chen

8

1 reference

2 September 2017

Xin Wu

9

1 reference

2 September 2017

publication date

1 November 2004

1 reference

Journal of Cancer Research and Clinical Oncology

2 September 2017

published in

1 reference

2 September 2017

volume

130

1 reference

2 September 2017

issue

11

1 reference

2 September 2017

page(s)

671-678

1 reference

Axil, a member of the Axin family, interacts with both glycogen synthase kinase 3beta and beta-catenin and inhibits axis formation of Xenopus embryos

2 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-004-0580-9

Restricted high level expression of Tcf-4 protein in intestinal and mammary gland epithelium

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-004-0580-9

Association of hTcf-4 gene expression and mutation with clinicopathological characteristics of hepatocellular carcinoma

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-004-0580-9

Apoptosis and APC in colorectal tumorigenesis

21 January 2018

1 reference

12 December 2020

A randomized phase II and pharmacokinetic study of the antisense oligonucleotides ISIS 3521 and ISIS 5132 in patients with hormone-refractory prostate cancer

1 reference

12 December 2020

Identification of c-MYC as a target of the APC pathway

1 reference

12 December 2020

Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma

1 reference

12 December 2020

The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell.

1 reference

12 December 2020

Wnt signaling and cancer

1 reference

12 December 2020

Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin

1 reference

12 December 2020

Measurement of protein using bicinchoninic acid

1 reference

12 December 2020

The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro

1 reference

12 December 2020

Transient overexpression of murine dishevelled genes results in apoptotic cell death.

1 reference

12 December 2020

Wnt signaling in oncogenesis and embryogenesis--a look outside the nucleus

1 reference

12 December 2020

Suppression of beta-catenin inhibits the neoplastic growth of APC-mutant colon cancer cells.

1 reference

12 December 2020

Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides

1 reference

12 December 2020

Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers

1 reference

12 December 2020

Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC

1 reference

12 December 2020

Antisense pharmacodynamics: critical issues in the transport and delivery of antisense oligonucleotides

1 reference

12 December 2020

Wnt-1 signaling inhibits apoptosis by activating beta-catenin/T cell factor-mediated transcription

1 reference

12 December 2020

Molecular mechanisms of action of antisense drugs

1 reference

12 December 2020

Wnt signaling: a common theme in animal development

1 reference

12 December 2020

A phase I trial of ISIS 2503, an antisense inhibitor of H-ras, in combination with gemcitabine in patients with advanced cancer.

1 reference

12 December 2020

Nucleic acid therapeutics: state of the art and future prospects.

1 reference

12 December 2020

Antisense oligonucleotides: an evolving technology for the modulation of gene expression in human disease

1 reference

12 December 2020

Exogenous expression of beta-catenin regulates contact inhibition, anchorage-independent growth, anoikis, and radiation-induced cell cycle arrest

1 reference

12 December 2020

Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis).

1 reference

12 December 2020

Critical aspects in the analysis of apoptosis and necrosis

1 reference

12 December 2020

Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta

1 reference

12 December 2020

How to design an antisense oligodeoxynucleotide experiment: a consensus approach

1 reference

12 December 2020

An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of beta-catenin

1 reference

12 December 2020

Phase I trial of BCL-2 antisense oligonucleotide (G3139) administered by continuous intravenous infusion in patients with advanced cancer

1 reference

12 December 2020

Advances in Understanding the Pharmacological Properties of Antisense Oligonucleotides

1 reference

12 December 2020

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

1 reference

12 December 2020

A review of the issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides

1 reference

12 December 2020

More than one way to skin a catenin

1 reference

12 December 2020

beta-catenin signaling and cancer

1 reference

12 December 2020

The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation

1 reference

12 December 2020

Cell-penetrating peptides.

1 reference

12 December 2020

Functional interaction of beta-catenin with the transcription factor LEF-1

1 reference

12 December 2020

Impaired mammary gland and lymphoid development caused by inducible expression of Axin in transgenic mice

1 reference

12 December 2020

TCF transcription factors: molecular switches in carcinogenesis

1 reference

12 December 2020

Enhanced delivery of antisense oligonucleotides with fluorophore-conjugated PAMAM dendrimers

1 reference

12 December 2020

A pilot trial of G3139, a bcl-2 antisense oligonucleotide, and paclitaxel in patients with chemorefractory small-cell lung cancer.

1 reference

12 December 2020

10.1007/S00432-004-0580-9

Identifiers

DOI

1 reference

2 September 2017

1 reference